Zimbabwe has rejected a major US health deal valued at $367m (272 million pounds) over five years over Washington's demand for sensitive biological samples.
This move was revealed after a internal memorandum from December was disclosed, indicating that President Emmerson Mnangagwa deemed the agreement was "skewed".
A government spokesperson later explained that the United States was demanding access to biological samples for research and commercial purposes but was unwilling to guarantee the resulting advantages from future medical innovations.
"We will now turn to the challenging and unfortunate task of scaling back our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had donated more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for more talks to secure a agreement acceptable to both sides so the nation's vital HIV programme can be sustained.
Wider Implications
This rejection follows a similar case in neighbouring Kenya, where a high court suspended a similar health funding agreement after concerns were raised about the security of citizens' medical information.
Since returning to the presidency last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
The agency had overseen assistance for the American government, but Trump claimed its expenditure was "inefficient" and his administration was seeking government-to-government deals to boost openness and accountability.
Based on reports, 16 African countries have so far signed similar agreements, constituting over $18.3bn in new funding.
Specifics of the Rejected Deal
This assistance for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation might have yielded significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment through US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, with no equivalent guarantee of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that provided information," he stated.
"Put simply, our country would provide the raw materials for scientific discovery without any certainty that the end products would be accessible to our population should a future health crisis arise."
National Interest and Global Health
He also pointed out that the American exit from the global health body and its pursuit of bilateral health agreements were upending frameworks previously established via the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to manage future pandemics.
"This mechanism is intended to guarantee that when a nation contributes its data, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to create them."
Zimbabwe's reservations regarding the US deal "are not meant as anti-American sentiment," he added.
"We encourage ongoing dialogue with our American counterparts on how subsequent collaboration might be structured in a way that honours the independence and interests of both nations."
Medical Community Response
Medical experts said it understood the government's concerns, but recommended that negotiations must proceed considering much of the nation's Aids initiatives were funded by external financing.
"In cases where technical issues arise, including those involving information security or implementation frameworks, these can often be resolved through technical clarification and mutually agreed protections," the group said.
The halted deal highlights the continuing tensions between receiving much-needed foreign assistance and safeguarding local interests in an ever more interconnected world.